Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.9140
-0.0359 (-3.78%)
At close: Mar 11, 2026, 4:00 PM EDT
0.9100
-0.0040 (-0.44%)
After-hours: Mar 11, 2026, 7:12 PM EDT
Revenue by Segment
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Pipeline Research and Development (Pipeline R&D) | | 381.00K | 699.00K | 578.00K | 343.00K | 674.00K | | | | |
Pipeline Research and Development (Pipeline R&D) Growth | | -45.49% | 20.93% | 68.51% | -49.11% | -65.22% | | | | |
| | 381.00K | 699.00K | 578.00K | 343.00K | 674.00K | | | | |
| | -45.49% | 20.93% | 68.51% | -49.11% | -65.22% | | | | |
Revenue by Geography
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| | 381.00K | 699.00K | 578.00K | 114.00K | - | | | | |
| | -45.49% | 20.93% | 407.02% | - | - | | | | |
| | - | - | - | 4.00K | 197.00K | | | | |
| | - | - | - | -97.97% | 32.21% | | | | |
| | - | - | - | 62.00K | 60.00K | | | | |
| | - | - | - | 3.33% | - | | | | |
| | - | - | - | - | 55.00K | | | | |
| | 381.00K | 699.00K | 578.00K | 180.00K | 312.00K | | | | |
| | -45.49% | 20.93% | 221.11% | -42.31% | 109.40% | | | | |
Source: S&P Global Market Intelligence.